A scientific review: Mechanisms of valproate-mediated teratogenesis

Bioscience Horizons

Volumn 6, Issue , 2013, Pages

  Lloyd, Katie Alexandra ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Anticonvulsants; Birth defects; Epilepsy; Pregnancy; Teratogenicity; Valproate

Indexed keywords

EID: 84887684334     PISSN: None     EISSN: 17547431     Source Type: Journal    
DOI: 10.1093/biohorizons/hzt003     Document Type: Review

References (67)

1. Abramov, J. P. and Wells, P. G. (2011) Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice, FASEB Journal, 25, 2188-2200.
2. Alsdorf, R. and Wyszynski, D. F. (2005) Teratogenicity of sodium valproate, Expert Opinion on Drug Safety, 4, 345-353. (Pubitemid 40867344)
3. Atkinson, D. E., Brice-Bennett, S. and D'Souza, S. W. (2007) Antiepileptic medication during pregnancy: does fetal genotype affect outcome? Pediatric Research, 62, 120-127. (Pubitemid 47205707)
4. Baltes, S., Fedrowitz, M., Tortós, C. L. et al. (2007) Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays, Journal of Pharmacology and Experimental Therapeutics, 320, 331-343. (Pubitemid 46025748)
5. Butterworth, C. E., Jr and Bendich, A. (1996) Folic acid and the prevention of birth defects., Annual Review of Nutrition, 16, 73-97. (Pubitemid 26286847)
6. Campbell, N. A., Reece, J. B., Urry, L. A. et al. (2008) Biology, Pearson Benjamin Cummings, San Fransisco.
7. Chiu, C.-T., Wang, Z., Hunsberger, J. G. et al. (2013) Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder, Pharmacological Reviews, 65, 105-142.
8. Choi, J. C., Holtz, R. and Murphy, S. P. (2009) Histone deacetylases inhibit IFN-?-inducible gene expression in mouse trophoblast cells, Journal of Immunology, 182, 6307-6315.
9. Chuang, C. M., Chang, C. H., Wang, H. E. et al. (2012) Valproic acid downregulates RBP4 and elicits hypervitaminosis A-teratogenesis-A kinetic analysis on retinol/retinoic acid homeostatic system, PLoS ONE, 7, e43692.
10. Chung B. H. Y., Ip, P., Chow, C. B. et al. (2011) Teratology and developmental pharmacology: why should paediatricians care? Hong Kong Journal of Paediatrics, 16, 264-272.
11. Comelli, N. C., Duchowicz, P. R., Lobayan, R. M. et al. (2012) QSPR study of valproic acid and its functionalized derivatives, Molecular Informatics, 31, 181-188.
12. Copp, A. J., Greene, N. D., and Murdoch, J. N. (2003) The genetic basis of mammalian neurulation, National Review of Genetics, 4, 784-793. (Pubitemid 37193270)
13. Dawson, J. E., Raymond, A. M. and Winn, L. M. (2006) Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice, Toxicology and Applied Pharmacology, 211, 124-132. (Pubitemid 43238306)
14. Dean, J., Robertson, Z., Reid, V. et al. (2007) Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR, American Journal of Medical Genetics, Part A, 143, 2303-2311. (Pubitemid 47509646)
15. Downing, C., Biers, J., Larson, C. et al. (2010) Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice, Toxicological Sciences, 116, 632-639.
16. Duncan, J. S., Sander, J. W., Sisodiya, S. M. et al. (2006) Adult epilepsy, Lancet (London, England), 367, 1087-1100.
17. Eadie, M. J. (2008) Antiepileptic drugs as human teratogens, Expert Opinion on Drug Safety, 7, 195-209. (Pubitemid 351447702)
18. Göttlicher, M. (2004) Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases, Annals of Hematology, 83(Suppl. 1), S91-S92.
19. Grunstein, M. (1997) Histone acetylation in chromatin structure and transcription, Nature, 389, 349-352. (Pubitemid 27415209)
20. Hill, D. S., Wlodarczyk, B. J., Palacios, A. M. et al. (2010) Teratogenic effects of antiepileptic drugs, Expert Review of Neurotherapeutics, 10, 943-959.
21. Holmes, L. B. (2011) Human teratogens: update 2010, Birth Defects Research Part A - Clinical and Molecular Teratology, 91, 1-7.
22. Houghton, B. L. and Bowers, J. B. (2003) Valproic acid overdose: a case report and review of therapy, Medscape General Medicine 5, 5-11.
23. Hsieh, C. L., Wang, H. E., Tsai, W. J. et al. (2012) Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, And N-acetylcysteine in chicken embryo model, Toxicology, 291, 32-42.
24. Jentink, J., Bakker, M. K., Nijenhuis, C. M. et al. (2010) Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid? Pharmacoepidemiology and Drug Safety, 19, 803-807.
25. Johannessen, C. U. and Johannessen, S. I. (2003) Valproate: past, present, and future, CNS Drug Reviews, 9, 199-216.
26. Kalhan, S. C. and Marczewski, S. E. (2012) Methionine, homocysteine, one carbon metabolism and fetal growth, Reviews in Endocrine and Metabolic Disorders, 13, 109-119.
27. Kammerer, M., Rassner, M. P., Freiman, T. M. et al. (2011) Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes, Naunyn-Schmiedeberg's Archives of Pharmacology, 384, 47-57.
28. Keranen, T. and Sivenius, J. (1983) Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy, Acta Neurologica Scandinavica Supplementum, 97, 69-80.
29. Kini, U., Lee, R., Jones, A. et al. (2007) Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero, European Journal of Medical Genetics, 50, 411-420. (Pubitemid 350161482)
30. Kishi, T., Fujita, N., Eguchi, T. A. et al. (1997) Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy, Journal of the Neurological Sciences, 145, 109-112. (Pubitemid 27141588)
31. Klein, A. M. (2011) Epilepsy cases in pregnant and postpartum women: a practical approach, Seminars in Neurology, 31, 392-396.
32. Kuo, M.-H. and Allis, C. D. (1998) Roles of histone acetyltransferases and deacetylases in gene regulation, BioEssays, 20, 615-626. (Pubitemid 28422221)
33. Large, C. H., Kalinichev, M., Lucas, A. et al. (2009) The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the rat, Epilepsy Research, 85, 96-106.
34. Li, G. and Reinberg, D. (2011) Chromatin higher-order structures and gene regulation, Current Opinion in Genetics & Development, 21, 175-186.
35. Liu, H., Fu, R. Y., Liao, Q. K. et al. (2009) Valproic acid induced intracellular GSH-redox imbalance and apoptosis of leukemic cells resistant to dexamethasone and doxorubicin, Journal of Sichuan University (Medical Science Edition), 40, 133-137.
36. Massa, V., Cabrera, R. M., Menegola, E. et al. (2005) Valproic acid-induced skeletal malformations: associated gene expression cascades, Pharmacogenetics and Genomics, 15, 787-800. (Pubitemid 41531728)
37. Menegola, E., Di Renzo, F., Broccia, M. L. et al. (2005) Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity, Birth Defects Research Part B - Developmental and Reproductive Toxicology, 74, 392-398. (Pubitemid 41579582)
38. Morland, C., Nordengen, K. and Gundersen, V. (2012) Valproate causes reduction of the excitatory amino acid aspartate in nerve terminals, Neuroscience Letters, 527, 100-104.
39. Okada, A., Noyori, H., Yagen, B. et al. (2009) Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice, Birth Defects Research Part B - Developmental and Reproductive Toxicology, 86, 394-401.
40. Ornoy, A. (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reproductive Toxicology, 28, 1-10.
41. Pan, H., Cao, J. and Xu, W. (2012) Selective histone deacetylase inhibitors, Anti-Cancer Agents in Medicinal Chemistry, 12, 247-270.
42. Pelicano, H., Carney, D. and Huang, P. (2004) ROS stress in cancer cells and therapeutic implications, Drug Resistance Updates, 7, 97-110. (Pubitemid 38736063)
43. Pennings, J. L. A., Van Dartel, D. A. M., Robinson, J. F. et al. (2011) Gene set assembly for quantitative prediction of developmental toxicity in the embryonic stem cell test, Toxicology, 284, 63-71.
44. Pontiki, E. and Hadjipavlou-Litina, D. (2012) Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: history and new QSAR perspectives, Medicinal Research Reviews, 32, 1-165.
45. Pulikkunnel, S. T. and Thomas, S. V. (2005) Neural tube defects: pathogenesis and folate metabolism, Journal of Association of Physicians of India, 53, 127-135. (Pubitemid 41280117)
46. Rodriguez-Sainz A., Pinedo-Brochado, A., Sánchez-Menoyo, J. L. et al. (2013) Migraine, stroke and epilepsy: underlying and interrelated causes, diagnosis and treatment, Current Treatment Options in Cardiovascular Medicine, 1-13.
47. Roy, M., Leclerc, D., Wu, Q. et al. (2008) Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency, Journal of Cellular Biochemistry, 105, 467-476.
48. Sankar, R. (2007) Teratogenicity of antiepileptic drugs: role of drug metabolism and pharmacogenomics, Acta Neurologica Scandinavica, 116, 65-71. (Pubitemid 46976272)
49. Scott, W. J., JR, Schreiner, C. M., Nau, H. et al. (1997) Valproate-induced limb malformations in mice associated with reduction of intracellular pH, Reproductive Toxicology, 11, 483-493.
50. Sekine, T., Cha, S. H. and Endou, H. (2000) The multispecific organic anion transporter (OAT) family, Pflugers Archiv European Journal of Physiology, 440, 337-350. (Pubitemid 30445708)
51. Shen, D. D. (1999) Valproate, in W. Loscher, ed., Milestones in Drug Therapy, Birkhauser Verlag, Switzerland.
52. Signorile, P. G., Baldi, F., Bussani, R. et al. (2012) Embryologic origin of endometriosis: analysis of 101 human female fetuses, Journal of Cellular Physiology, 227, 1653-1656.
53. Stephen, L. J., Forsyth, M., Kelly, K. et al. (2012) Antiepileptic drug combinations- have newer agents altered clinical outcomes? Epilepsy Research, 98, 194-198.
54. Tomson, T. and Battino, D. (2009) Teratogenic effects of antiepileptic medications, Neurologic Clinics, 27, 993-1002.
55. Tornes, L. and Harden, C. L. (2010) Antiepileptic drug pregnancy registries: do the latest findings concur? Therapy, 7, 517-526.
56. Tung, E. W. Y. and Winn, L. M. (2010) Epigenetic modifications in valproic acid-induced teratogenesis, Toxicology and Applied Pharmacology, 248, 201-209.
57. Tung, E. W. Y. and Winn, L. M. (2011) Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects, Molecular Pharmacology, 80, 979-987.
58. Utoguchi, N. and Audus, K. L. (2000) Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line, International Journal of Pharmaceutics, 195, 115-124. (Pubitemid 30089496)
59. Vajda, F. (2012) Dose issues in antiepileptic therapy, Journal of Clinical Neuroscience, 19, 1475-1477.
60. Verrotti, A., Scardapane, A., Franzoni, E. et al. (2008) Increased oxidative stress in epileptic children treated with valproic acid, Epilepsy Research, 78, 171-177.
61. Vorobeychik, Y., Gordin, V., Mao, J. et al. (2011) Combination therapy for neuropathic pain: a review of current evidence, CNS Drugs, 25, 1023-1034.
62. Wells, P. G., Lee, C. J. J., Mccallum, G. P. et al. (2010) Receptor- and reactive intermediate-mediated mechanisms of teratogenesis, Handb Exp Pharmacol, 196, 131-62.
63. Werler, M. M., Ahrens, K. A., Bosco, J. L. F. et al. (2011) Use of antiepileptic medications in pregnancy in relation to risks of birth defects, Annals of Epidemiology, 21, 842-850.
64. Wilffert, B., Altena, J., Tijink, L. et al. (2011) Pharmacogenetics of drug-induced birth defects: what is known so far? Pharmacogenomics, 12, 547-558.
65. Wu, G., Nan, C., Rollo, J. C. et al. (2010) Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase, Journal of Biomedical Science, 17, 16-22.
66. Zaccara, G., Franciotta, D. and Perucca, E. (2007) Idiosyncratic adverse reactions to antiepileptic drugs, Epilepsia, 48, 1223-1244. (Pubitemid 47063067)
67. Zaken, V., Kohen, R. and Ornoy, A. (2000) The development of antioxidant defense mechanism in young rat embryos in vivo and in vitro, Early Pregnancy, 110-123.